http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100553634-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb9c6b40161bafe7bd55f0b4defcea04 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 |
| filingDate | 2003-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4bbd1d48a487895d84fd15f343bc23f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ed087f92629b45d108caeaecb3b7e88 |
| publicationDate | 2009-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-100553634-C |
| titleOfInvention | The epothilone derivate that is used for the treatment of multiple myeloma |
| abstract | The present invention relates to suffering from myeloma, especially suffering from the method that has the homoiothermic animal of the myeloma of resistance, especially people to treat to conventional cell toxicant chemotherapy, this method comprises that Epothilones, especially formula (I) Epothilones with the treatment effective dose is applied to described animal; Relate to and being used for simultaneously, respectively or the combination of using successively that comprises Epothilones; And relate to pharmaceutical composition and the commercial packing that comprises described combination. |
| priorityDate | 2002-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 125.